Matrix metalloproteinases in tumour invasion and metastasis

S Curran, G I Murray

Research output: Contribution to journalLiterature review

577 Citations (Scopus)

Abstract

The matrix metalloproteinases (MMPs) are a large family of proteolytic enzymes, which are involved in the degradation of many different components of the extracellular matrix. The MMPs have been classified into different groups including collagenases, gelatinases, stromelysins, and others, particularly membrane-type MMPs, based mainly on the in vitro substrate specificity of individual MMPs. There is increasing evidence to indicate that individual MMPs have important roles in tumour invasion and metastasis. However, the current concept of the role of MMPs in tumour invasion is that they not only have a direct role in tumour invasion by facilitating extracellular matrix degradation, but as a consequence they also have an important role in maintaining the tumour micro-environment and thus promoting tumour growth. Inhibiting the action of MMPs represents a new therapeutic approach for the treatment of individual types of cancer and several broad-spectrum, low-molecular-weight MMP inhibitors are currently being assessed for clinical use. This review examines the role of MMPs in tumour invasion and metastasis, with an emphasis on studies of clinical relevance. Copyright (C) 1999 John Wiley & Sons, Ltd.

Original languageEnglish
Pages (from-to)300-308
Number of pages9
JournalThe Journal of pathology
Volume189
Publication statusPublished - 1999

Keywords

  • matrix metalloproteinase
  • collagenase
  • neoplasm
  • breast
  • colon
  • lung
  • tissue inhibitor of matrix metalloproteinase
  • MESSENGER-RNA EXPRESSION
  • HUMAN GASTRIC CARCINOMAS
  • HUMAN PROSTATE-CANCER
  • TISSUE INHIBITOR
  • COLORECTAL-CANCER
  • BREAST-CANCER
  • IV COLLAGENASE
  • MONOCLONAL-ANTIBODIES
  • GELATINASE-A
  • CLINICOPATHOLOGICAL CORRELATIONS

Cite this

Matrix metalloproteinases in tumour invasion and metastasis. / Curran, S ; Murray, G I .

In: The Journal of pathology, Vol. 189, 1999, p. 300-308.

Research output: Contribution to journalLiterature review

@article{3b50e88479824392acc02dd7f2857d66,
title = "Matrix metalloproteinases in tumour invasion and metastasis",
abstract = "The matrix metalloproteinases (MMPs) are a large family of proteolytic enzymes, which are involved in the degradation of many different components of the extracellular matrix. The MMPs have been classified into different groups including collagenases, gelatinases, stromelysins, and others, particularly membrane-type MMPs, based mainly on the in vitro substrate specificity of individual MMPs. There is increasing evidence to indicate that individual MMPs have important roles in tumour invasion and metastasis. However, the current concept of the role of MMPs in tumour invasion is that they not only have a direct role in tumour invasion by facilitating extracellular matrix degradation, but as a consequence they also have an important role in maintaining the tumour micro-environment and thus promoting tumour growth. Inhibiting the action of MMPs represents a new therapeutic approach for the treatment of individual types of cancer and several broad-spectrum, low-molecular-weight MMP inhibitors are currently being assessed for clinical use. This review examines the role of MMPs in tumour invasion and metastasis, with an emphasis on studies of clinical relevance. Copyright (C) 1999 John Wiley & Sons, Ltd.",
keywords = "matrix metalloproteinase, collagenase, neoplasm, breast, colon, lung, tissue inhibitor of matrix metalloproteinase, MESSENGER-RNA EXPRESSION, HUMAN GASTRIC CARCINOMAS, HUMAN PROSTATE-CANCER, TISSUE INHIBITOR, COLORECTAL-CANCER, BREAST-CANCER, IV COLLAGENASE, MONOCLONAL-ANTIBODIES, GELATINASE-A, CLINICOPATHOLOGICAL CORRELATIONS",
author = "S Curran and Murray, {G I}",
year = "1999",
language = "English",
volume = "189",
pages = "300--308",
journal = "The Journal of pathology",
issn = "0022-3417",
publisher = "Wiley",

}

TY - JOUR

T1 - Matrix metalloproteinases in tumour invasion and metastasis

AU - Curran, S

AU - Murray, G I

PY - 1999

Y1 - 1999

N2 - The matrix metalloproteinases (MMPs) are a large family of proteolytic enzymes, which are involved in the degradation of many different components of the extracellular matrix. The MMPs have been classified into different groups including collagenases, gelatinases, stromelysins, and others, particularly membrane-type MMPs, based mainly on the in vitro substrate specificity of individual MMPs. There is increasing evidence to indicate that individual MMPs have important roles in tumour invasion and metastasis. However, the current concept of the role of MMPs in tumour invasion is that they not only have a direct role in tumour invasion by facilitating extracellular matrix degradation, but as a consequence they also have an important role in maintaining the tumour micro-environment and thus promoting tumour growth. Inhibiting the action of MMPs represents a new therapeutic approach for the treatment of individual types of cancer and several broad-spectrum, low-molecular-weight MMP inhibitors are currently being assessed for clinical use. This review examines the role of MMPs in tumour invasion and metastasis, with an emphasis on studies of clinical relevance. Copyright (C) 1999 John Wiley & Sons, Ltd.

AB - The matrix metalloproteinases (MMPs) are a large family of proteolytic enzymes, which are involved in the degradation of many different components of the extracellular matrix. The MMPs have been classified into different groups including collagenases, gelatinases, stromelysins, and others, particularly membrane-type MMPs, based mainly on the in vitro substrate specificity of individual MMPs. There is increasing evidence to indicate that individual MMPs have important roles in tumour invasion and metastasis. However, the current concept of the role of MMPs in tumour invasion is that they not only have a direct role in tumour invasion by facilitating extracellular matrix degradation, but as a consequence they also have an important role in maintaining the tumour micro-environment and thus promoting tumour growth. Inhibiting the action of MMPs represents a new therapeutic approach for the treatment of individual types of cancer and several broad-spectrum, low-molecular-weight MMP inhibitors are currently being assessed for clinical use. This review examines the role of MMPs in tumour invasion and metastasis, with an emphasis on studies of clinical relevance. Copyright (C) 1999 John Wiley & Sons, Ltd.

KW - matrix metalloproteinase

KW - collagenase

KW - neoplasm

KW - breast

KW - colon

KW - lung

KW - tissue inhibitor of matrix metalloproteinase

KW - MESSENGER-RNA EXPRESSION

KW - HUMAN GASTRIC CARCINOMAS

KW - HUMAN PROSTATE-CANCER

KW - TISSUE INHIBITOR

KW - COLORECTAL-CANCER

KW - BREAST-CANCER

KW - IV COLLAGENASE

KW - MONOCLONAL-ANTIBODIES

KW - GELATINASE-A

KW - CLINICOPATHOLOGICAL CORRELATIONS

M3 - Literature review

VL - 189

SP - 300

EP - 308

JO - The Journal of pathology

JF - The Journal of pathology

SN - 0022-3417

ER -